Myasthenia gravis requiring pyridostigmine treatment in a national population cohort

Abstract

Reported prevalence and incidence are amongst the highest found in similar studies. This may be explained by optimal case identification, higher incidence of drug requiring MG amongst the elderly, and recurrences of previous MG.